Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women. Read more about Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.
Hepatitis C virus seroconversion among young injection drug users: relationships and risks. Read more about Hepatitis C virus seroconversion among young injection drug users: relationships and risks.
Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV. Read more about Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV.
The impact of anemia on quality of life in human immunodeficiency virus-infected patients. Read more about The impact of anemia on quality of life in human immunodeficiency virus-infected patients.
Introduction: the importance of identifying and treating complications of human immunodeficiency virus disease. Read more about Introduction: the importance of identifying and treating complications of human immunodeficiency virus disease.
Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant. Read more about Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant.
Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis. Read more about Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
Use of tissue culture-amplified human immunodeficiency virus type 1 to study evolutionary changes in vivo. Read more about Use of tissue culture-amplified human immunodeficiency virus type 1 to study evolutionary changes in vivo.
Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. Read more about Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers. Read more about Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers.
